Therapeutic implications of menin inhibition in acute leukemias
Por um escritor misterioso
Descrição
Frontiers Molecular Approaches to Treating Pediatric Leukemias
Full article: Emerging small molecular inhibitors as targeted
Treatment for Relapsed/Refractory Acute Myeloid Leukemia
Acute Leukemias
Revumenib: a new therapy for AML patients
The clinical impact of the molecular landscape of acute myeloid
Cancers, Free Full-Text
A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression
Current status and future perspectives in targeted therapy of NPM1
Targeting of epigenetic co-dependencies enhances anti-AML efficacy
Stabilizing the Mixed Lineage Leukemia Protein
ASH: Novel menin inhibitors show promise for patients with
Targeting menin induces responses in acute leukemias with KMT2A
de
por adulto (o preço varia de acordo com o tamanho do grupo)